Journal article 1264 views
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
G. B. Bolli,
D. R. Owens,
David Owens 
Diabetes, Obesity and Metabolism, Volume: 16, Issue: 7, Pages: 588 - 601
Swansea University Author:
David Owens
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1111/dom.12253
Abstract
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
| Published in: | Diabetes, Obesity and Metabolism |
|---|---|
| Published: |
2014
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa26727 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Issue: |
7 |
| Start Page: |
588 |
| End Page: |
601 |